Neuronal instability: implications for Rett's syndrome

被引:31
作者
Azmitia, EC
机构
[1] NYU, Dept Biol, New York, NY 10003 USA
[2] NYU, Dept Psychiat, New York, NY 10003 USA
[3] NYU, Ctr Neural Sci, New York, NY 10003 USA
关键词
serotonin; 5-HT1A; MAP-2; regression; BDNF; S-100; cytoskeleton; apoptosis; petal alcohol syndrome; cocaine; autism;
D O I
10.1016/S0387-7604(01)00368-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The maturational changes in the brain and spinal cord do not linearly proceed from immature in infants to mature in adults. Dendrites dynamically extend or retract as neurotrophic factors fluctuate. In certain cases mature neurons can be seen soon after birth, and in other cases immature neurons can be identified in the aged brain. Monoamine 'neurotransmitter'; such as serotonin (5-HT), dopamine and norepinephrine appear to function as Maintenance Growth Factors since they must be present in order to produce their maturational actions. Serotonin neurons contain TRK-B receptors and are sensitive to availability of the trophic factor, BDNF. 5-HT also functions by promoting the release of the glial extension factor, S-100beta. 5-HT and S-100beta can provide maturational signals to a variety of neurons, in both cortical and subcortical areas, and appear to be involved in regulating the maturation and release of acetylcholine and dopamine. We have shown that activation of the 5-HT1A receptor is particularly effective in inducing growth of stunted neurons. The mechanism of action of the 5-HT1A receptor involves both a direct inhibition on c-AMP and pCREB formation in postsynaptic neurons and a release of S-100beta from glial cells. Both these events are capable of stabilization and elaboration of the cytoskeleton of the neuron and inhibition of apoptosis. 5-HT1A receptors have been shown to effectively reverse stunted neurons and microencephaly produced,in animal models of fetal alcohol syndrome and prenatal cocaine administration. I discuss the implications for regressive disorders such as Rett's syndrome and autism, and the feasibility of treatments with 5-HT1A agonists in children with developmental disorders. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:S1 / S10
页数:10
相关论文
共 88 条
[1]   S-100β protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT1A-receptor agonist, Bay x 3702 [J].
Ahlemeyer, B ;
Beier, H ;
Semkova, I ;
Schaper, C ;
Krieglstein, J .
BRAIN RESEARCH, 2000, 858 (01) :121-128
[2]   PRENATAL COCAINE DECREASES THE TROPHIC FACTOR S-100-BETA AND INDUCED MICROCEPHALY - REVERSAL BY POSTNATAL 5-HT1A RECEPTOR AGONIST [J].
AKBARI, HM ;
WHITAKERAZMITIA, PM ;
AZMITIA, EC .
NEUROSCIENCE LETTERS, 1994, 170 (01) :141-144
[3]   The 5HT1A receptor: Signaling, desensitization, and gene transcription [J].
Albert, PR ;
Lembo, P ;
Storring, JM ;
Charest, A ;
Saucier, C .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (01) :19-25
[4]  
ALBERT PR, 1990, J BIOL CHEM, V265, P5825
[5]   PLASTICITY IN BRAIN-DEVELOPMENT [J].
AOKI, C ;
SIEKEVITZ, P .
SCIENTIFIC AMERICAN, 1988, 259 (06) :56-64
[6]   Organ growth in Rett syndrome: A postmortem examination analysis [J].
Armstrong, DD ;
Dunn, JK ;
Schultz, RJ ;
Herbert, DA ;
Glaze, DG ;
Motil, KJ .
PEDIATRIC NEUROLOGY, 1999, 20 (02) :125-129
[7]  
Azmitia E. C., 1997, HDB EXPT PHARM SEROT, P1
[8]   Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells [J].
Azmitia, EC ;
Gannon, PJ ;
Kheck, NM ;
WhitakerAzmitia, PM .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (01) :35-46
[9]  
AZMITIA EC, 1994, ANN NY ACAD SCI, V746, P180
[10]   5-HT1A AGONIST AND DEXAMETHASONE REVERSAL OF PARA-CHLOROAMPHETAMINE INDUCED LOSS OF MAP-2 AND SYNAPTOPHYSIN IMMUNOREACTIVITY IN ADULT-RAT BRAIN [J].
AZMITIA, EC ;
RUBINSTEIN, VJ ;
STRAFACI, JA ;
RIOS, JC ;
WHITAKERAZMITIA, PM .
BRAIN RESEARCH, 1995, 677 (02) :181-192